IDG Capital Leads $67M Series C Round In Biotech Start-Up HiFiBiO Therapeutics

For Digital Subscribers Only

HiFiBiO Therapeutics, a multinational biotherapeutics start-up that mobilizes the human immune system to combat disease, announced on Wednesday the completion of a US$67 million series C round of financing led by Boston-born investment company IDG Capital.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

RELATED NEWS



LEAVE A REPLY